Chronic Pain — Effects of Brief Guided Imagery for Chronic Pain in Patients Diagnosed With Fibromyalgia
Citation(s)
Baird CL, Sands L A pilot study of the effectiveness of guided imagery with progressive muscle relaxation to reduce chronic pain and mobility difficulties of osteoarthritis. Pain Manag Nurs. 2004 Sep;5(3):97-104.
Carlsson AM Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983 May;16(1):87-101. doi: 10.1016/0304-3959(83)90088-X.
Chandra A, Ozturk A Quality of life issues and assessment tools as they relate to patients with chronic nonmalignant pain. Hosp Top. 2005 Winter;83(1):33-7.
Cleeland CS, Ryan KM Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38. Review.
D'Antoni ML, Harvey PL, Fried MP Alternative medicine: does it play a role in the management of voice disorders? J Voice. 1995 Sep;9(3):308-11.
Felce D, Perry J Quality of life: its definition and measurement. Res Dev Disabil. 1995 Jan-Feb;16(1):51-74. Review.
McHorney CA, Haley SM, Ware JE Jr Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods. J Clin Epidemiol. 1997 Apr;50(4):451-61.
Richter K, Egger R, Negri L, Corsi R, Severini C, Kreil G cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4836-9.
Twycross A Nurses' views about the barriers and facilitators to effective management of pediatric pain. Pain Manag Nurs. 2013 Dec;14(4):e164-e172. doi: 10.1016/j.pmn.2011.10.007. Epub 2011 Dec 14.
Effects of Brief Guided Imagery for Chronic Pain in Patients Diagnosed With Fibromyalgia
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
